Seyed Sadegh Eslami

Seyed Sadegh Eslami

Auto-generated profile, based on publicly available information

Seyed Sadegh Eslami

Baker Heart and Diabetes Institute, Melbourne, Victoria 3004, Australia; Baker Department of Cardiovascular Research, Translation and Implementation La Trobe University, Melbourne, Victoria 3086, Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2024 in Nanoscale
Verified
Journal Article
Open access
PDF file
RCRocky Chowdhury
Rocky Chowdhury
SESeyed Sadegh Eslami
Seyed Sadegh Eslami
CPCuong Viet Pham
Cuong Viet Pham
ARAlin Rai
Alin Rai
JLJia Lin
Jia Lin
Wei DuanWei Duan
Wei Duan
This review summarizes how aptamers (chemical antibodies) at the molecular level propel the advancement of the application of nano-scaled extracellular vesicles in nanotechnology and medicine, highlighting the latest developments since 2023.

18 March 2025 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
HFHaoyun Fang
Haoyun Fang
ARAlin Rai
Alin Rai
SESeyed Sadegh Eslami
Seyed Sadegh Eslami
KHKevin Huynh
Kevin Huynh
HLHsiao-Chi Liao
Hsiao-Chi Liao
DGDavid Greening
David Greening
Protein compartmentalization to distinctive subcellular niches is critical for cardiac function and homeostasis. Here, we employed a rapid and robust workflow based on differential centrifugal-based fractionation with mass spectrometry-based proteomics and bioinformatic analyses for systemic mapping of the subcellular proteome of mouse heart. Using supervised machine learning of 450 hallmark protein markers from 16 subcellular niches, we further refined the subcellular information of 2083 proteins with high confidence. Our data validation focused on specific subcellular niches such as mitochondria, cell surface, cardiac dyad, myofibril, and nuclear, unfolding dominant subcellular localization of proteins in their native environment of mouse heart. We further provide targeted nuclear enrichment and co-immunoprecipitation-based proteomic validation from the heart of nuclear-localizing protein networks. This study provides novel insights into the molecular landscape of different subcellular niches of the heart and serves as a draft map for heart subcellular proteome.

2 July 2022 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
SESeyed Sadegh Eslami
Seyed Sadegh Eslami
DJDavod Jafari
Davod Jafari
AGAbbas Ghotaslou
Abbas Ghotaslou
MAMoein Amoupour
Moein Amoupour
AKAmir Asri Kojabad
Amir Asri Kojabad
MSMajid Sadeghizadeh
Majid Sadeghizadeh
Purpose: Chemotherapy drugs used to treat lung cancer are associated with drug resistance and severe side effects. There have been rising demands for new therapeutic candidates and novel approaches, including combination therapy. Here, we aimed to investigate the combinatorial effect of a dendrosomal formulation of curcumin (DNC) and daunorubicin (DNR) on the A549 lung cancer cell line. Methods: We performed cytotoxicity, apoptosis, cell migration, colony-formation capacity, and gene expression analysis to interpret the mechanism of action for a combination of DNC and DNR on A549 cells. Results: Our results revealed that the combination of DNC and DNR could synergistically inhibit the A549 cells’ growth. This synergistic cytotoxicity was further approved by flow cytometry, migration assessment, colony-forming capacity and gene expression analysis. DNR combination with DNC resulted in increased apoptosis to necrosis ratio compared to DNR alone. In addition, the migration and colony-forming capacity were at the minimal range when DNC was combined with DNR. Combined treatment decreased the expression level of MDR-1, hTERT and Bcl-2 genes significantly. In addition, the ratio of Bax/Bcl2 gene expression significantly increased. Our analysis by free curcumin, dendrosomes and DNC also showed that dendrosomes do not have any significant cytotoxic effect on the A549 cells, suggesting that this carrier has a high potential for enhancing the curcumin’s biological effects. Conclusion: Our observations suggest that the DNC formulation of curcumin synergistically enhances the antineoplastic effect of DNR on the A549 cell line through the modulation of apoptosis/necrosis ratio, as well as Bax/Bcl2 ratio, MDR-1 and hTERT gene expression.

15 May 2026 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
SESeyed Sadegh Eslami
Seyed Sadegh Eslami
ARAlin Rai
Alin Rai
HFHaoyun Fang
Haoyun Fang
ATAnita C. Thomas
Anita C. Thomas
JCJonathon Cross
Jonathon Cross
DGDavid Greening
David Greening
Heart specialization involves nuclear programs however, chamber-specific regulation of the nuclear proteome landscape remains unknown. In this study we isolated the nucleus from four major anatomical regions of healthy mouse heart (fresh) and employed quantitative mass spectrometry-based proteomics to construct a comprehensive nuclear proteome landscape of left ventricle (LV, 2403 proteins), right ventricle (RV, 2242 proteins), left atrium (LA, 2368 proteins), right atrium (RA, 1816 proteins). This led to the discovery of nuclear regional proteome signatures [ventricular signature, 297 proteins; atrial signature, 183 proteins]; associated with oxidative metabolism and redox regulation, ferroptosis, extracellular-matrix remodeling, SUMO- and stress-responsive control and transcriptional regulation. Chamber-level analyses further identify distinct nuclear features in LV (120 proteins), LA (188 proteins), and RA (72 proteins). In addition, we defined conserved core nuclear proteome (230 proteins) shared across all anatomical regions, enriched for transcription-regulator complexes, nucleolar/ribosome-associated, RNA-processing, and chromatin-organization components. Within this core network we report 78 transcription factors/co-factors and select nuclear, chromatin and RNA export-associated proteins including 29 specific factors (e.g., Alpk3, Rbm14, Arglu1, Hmgb1, Myef2, Sf1) associated with the heart. Regionally, we verified spatial localization in heart of H2ac21 and Sun2 in LA and Ptbp2 in LV by immunofluorescence. This study provides insights into the chamber-resolved view of the nuclear proteome in the heart, establishes a framework for linking nuclear proteomic signatures to atrial and ventricular biology, unique features of the heart nuclear proteome landscape relative to other organs, and a baseline for studying nuclear remodeling in cardiac pathophysiology.